MyFinsight
Home
Blog
About
Contact
Download
Download image
Share-based compensation
expense
$44,685K
Depreciation
$12,090K
Amortization of intangible
assets
$8,441K
Proceeds from financing
obligation
$6,250K
Accrued liabilities
$6,997K
Acquired in-process
research and development...
$6,000K
Other non-cash
adjustments
$1,374K
Amortization of deferred
financing costs
$478K
Proceeds from issuance of
common stock under...
$5,923K
Proceeds from stock
option exercises
$1,367K
Net cash provided by
operating activities
$57,334K
Net cash provided by
(used in) financing...
$1,176K
Effect of exchange rate
changes on cash and cash...
$747K
Canceled cashflow
$22,731K
Canceled cashflow
$12,364K
Net increase in cash
and cash...
$44,707K
Canceled cashflow
$14,550K
Net loss
-$11,448K
Accounts receivable
$5,610K
Inventories
$2,256K
Other noncurrent
assets and liabilities
$2,129K
Accounts payable
-$960K
Other current assets
$328K
Proceeds from capital
grant
$500K
Shares repurchased for
payment of taxes on stock...
$11,163K
Payments on debt, leases
and financing...
$1,201K
Net cash (used in)
provided by investing...
-$14,550K
Canceled cashflow
$500K
Purchases of property and
equipment
$9,050K
Acquisitions, including
in-process research and...
$6,000K
Back
Back
Cash Flow
source: myfinsight.com
AtriCure, Inc. (ATRC)
AtriCure, Inc. (ATRC)